Clinical Trial Update: A Study for Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment in Patients With Chronic Renal Anaemia [Phase 4]

View source ↗

Summary

Phase 4 study evaluating monthly methoxy polyethylene glycol-epoetin beta for anemia of chronic kidney disease was terminated; results were posted in May 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 4 | Status: TERMINATED | Results posted: 2016-05-13